QA: Cambrex CORP in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2018_Cambrex_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000820081, Cambrex CORP

  xvar xval
0 AssetsCurrent 422,078,000
1 IntangibleAssetsNetIncludingGoodwill 57,494,000
2 PropertyPlantAndEquipmentNet 254,299,000
3 remainder_Assets 6,694,000
4 LiabilitiesCurrent 82,541,000
5 LiabilitiesNoncurrent 25,213,000
6 remainder_Liabilities 87,947,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 72,510,040
9 ResearchAndDevelopmentExpense 16,779,307
10 remainder_Expenses 341,825,582
11 remainder_Revenues 544,050,159
12 remainder_NetIncome -4,364,999
13 remainder_ComprehensiveNetIncome 28,920,144
  yvar yval
0 Assets 740,565,000
1 Liabilities 195,701,000
2 Expenses 431,114,929
3 Revenues 544,050,159
4 StockholdersEquity 544,864,000
5 NetIncome 108,570,231
6 ComprehensiveNetIncome 123,030,303
7 BaseVar 972,358,116
8 EconomicCapitalRatiobeforeLimitedLiability 2.80
9 EconomicCapitalRatio 3.55

Edgar->Model Mapping

Feature Distribution

Change over Time